A new community-based pickleball program called Project Rally is helping cancer survivors improve their physical and social well-being, according to a recent pilot study led by researchers at Moffitt Cancer Center. The program, which is […]
After years of decreasing amputations in the United States, rates of non-traumatic lower extremity amputations due to diabetes and related conditions are rising, and Oklahoma is among the states with the most pronounced increase, a […]
An international research team led by the Hong Kong University of Science and Technology (HKUST) has identified key genetic factors that confer protective effects against Alzheimer’s disease (AD) through a comprehensive genetic analysis of East […]
Nearly 60,000 people are diagnosed with oral cancer in the U.S. every year, according to the American Cancer Society, and the rate of new cases continues to rise. Now, researchers at University of California San […]
Scientists from DZNE, University Hospital Bonn (UKB) and the University of Bonn provide new evidence that preventing brain inflammation is a promising approach for the treatment of Alzheimer’s disease. Their findings, based on studies in […]
A recent study introduces an innovative method for analyzing body composition using advanced 3D imaging and deep learning techniques. This approach aims to provide more accurate assessments of body fat and muscle distribution, which are […]
For decades, scientists have tried to stop cancer by disabling the mutated proteins that are found in tumors. But many cancers manage to overcome this and continue growing. Now, UCSF scientists think they can throw […]
Physician–scientists at the University of Utah’s John A. Moran Eye Center have published an investigatory review of nine patients who experienced vision complications while taking popular semaglutide and tirzepatide drugs prescribed for diabetes and weight […]
Drinking ketones improves heart health, a new small-scale study from the University of Portsmouth has found. The research is published in the Journal of Applied Physiology.This article was originally published on MedicalXpress.com
Dexamphetamine—a restricted stimulant drug used to treat narcolepsy and Attention Deficient Hyperactivity Disorder (ADHD)—might not be as addictive as previously thought, new research from the University of Sydney suggests.This article was originally published on MedicalXpress.com
© 2025 SimplyWell.ca